“…We hypothesized that the isoflurane MAC‐sparing effects observed with some phenylpiperidine opioids might be mediated by nonopioid receptor effects. Fentanyl decreases neuronal release of acetylcholine to reduce muscarinic cholinergic activity (Mortazavi, Thompson, Baghdoyan, & Lydic, 1999), decreases release of glutamate that may reduce excitatory NMDA receptor currents, and increases release of γ‐aminobutyric acid (GABA) that may enhance inhibitory GABA A receptor currents (Pourzitaki et al., 2018). Additionally, various opioids at sufficient concentrations can directly modulate NMDA receptors (Hahnenkamp et al., 2004), α 1 ‐adrenergic receptors (Toda & Hatano, 1977), α 2 ‐adrenergic receptors (Hocker et al., 2008, 2009), dopamine receptors (Hagelberg et al., 2002), serotonin receptors (Leysen & Gommeren, 1986), voltage‐gated sodium channels (Leffler et al., 2012), and potassium channels (Tschirhart, Li, Guo, & Zhang, 2019).…”